§ 13F · FUND PROFILE
Frazier Life Sciences Management, L.P..
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 40Turnover · — · Q4Filed · Feb 13, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$3723.2T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | NAMS | NEWAMSTERDAM PHARMA COMPANY | 16.94M | $594.4T | 16.0% | NEW |
| 2 | MIRM | MIRUM PHARMACEUTICALS INC | 6.80M | $536.7T | 14.4% | NEW |
| 3 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | 9.87M | $286.8T | 7.7% | NEW |
| 4 | BBIO | BRIDGEBIO PHARMA INC | 3.55M | $271.2T | 7.3% | NEW |
| 5 | MBX | MBX BIOSCIENCES INC | 6.65M | $209.8T | 5.6% | NEW |
| 6 | PHAT | PHATHOM PHARMACEUTICALS INC | 12.47M | $206.8T | 5.6% | NEW |
| 7 | MAZE | MAZE THERAPEUTICS INC | 4.57M | $189.2T | 5.1% | NEW |
| 8 | TRVI | TREVI THERAPEUTICS INC | 10.26M | $128.4T | 3.5% | NEW |
| 9 | KRYS | KRYSTAL BIOTECH INC | 488K | $120.4T | 3.2% | NEW |
| 10 | IRON | DISC MEDICINE INC | 1.26M | $100.1T | 2.7% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE FRAZIER SIGNAL
AC read
Frazier Life Sciences Management, L.P. is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed